Literature DB >> 28548288

Hypermineralization and High Osteocyte Lacunar Density in Osteogenesis Imperfecta Type V Bone Indicate Exuberant Primary Bone Formation.

Stéphane Blouin1, Nadja Fratzl-Zelman1, Francis H Glorieux2, Paul Roschger1, Klaus Klaushofer1, Joan C Marini3, Frank Rauch2.   

Abstract

In contrast to "classical" forms of osteogenesis imperfecta (OI) types I to IV, caused by a mutation in COL1A1/A2, OI type V is due to a gain-of-function mutation in the IFITM5 gene, encoding the interferon-induced transmembrane protein 5, or bone-restricted interferon-inducible transmembrane (IFITM)-like protein (BRIL). Its phenotype distinctly differs from OI types I to IV by absence of blue sclerae and dentinogenesis imperfecta, by the occurrence of ossification disorders such as hyperplastic callus and forearm interosseous membrane ossification. Little is known about the impact of the mutation on bone tissue/material level in untreated and bisphosphonate-treated patients. Therefore, investigations of transiliac bone biopsy samples from a cohort of OI type V children (n = 15, 8.7 ± 4 years old) untreated at baseline and a subset (n = 8) after pamidronate treatment (2.6 years in average) were performed. Quantitative backscattered electron imaging (qBEI) was used to determine bone mineralization density distribution (BMDD) as well as osteocyte lacunar density. The BMDD of type V OI bone was distinctly shifted toward a higher degree of mineralization. The most frequently occurring calcium concentration (CaPeak) in cortical (Ct) and cancellous (Cn) bone was markedly increased (+11.5%, +10.4%, respectively, p < 0.0001) compared to healthy reference values. Treatment with pamidronate resulted in only a slight enhancement of mineralization. The osteocyte lacunar density derived from sectioned bone area was elevated in OI type V Ct and Cn bone (+171%, p < 0.0001; +183.3%, p < 0.01; respectively) versus controls. The high osteocyte density was associated with an overall immature primary bone structure ("mesh-like") as visualized by polarized light microscopy. In summary, the bone material from OI type V patients is hypermineralized, similar to other forms of OI. The elevated osteocyte lacunar density in connection with lack of regular bone lamellation points to an exuberant primary bone formation and an alteration of the bone remodeling process in OI type V.
© 2017 American Society for Bone and Mineral Research. © 2017 American Society for Bone and Mineral Research.

Entities:  

Keywords:  BISPHOSPHONATE TREATMENT; MATRIX MINERALIZATION; OSTEOCYTE LACUNAE; OSTEOGENESIS IMPERFECTA TYPE V; QUANTITATIVE BACKSCATTERED ELECTRON IMAGING

Mesh:

Substances:

Year:  2017        PMID: 28548288      PMCID: PMC5555797          DOI: 10.1002/jbmr.3180

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  52 in total

1.  The mineralization density of iliac crest bone from children with osteogenesis imperfecta.

Authors:  A Boyde; R Travers; F H Glorieux; S J Jones
Journal:  Calcif Tissue Int       Date:  1999-03       Impact factor: 4.333

2.  Hyperplastic callus formation, with or without evidence of a fracture, in osteogenesis imperfecta.

Authors:  H A T FAIRBANK
Journal:  Br J Surg       Date:  1948-07       Impact factor: 6.939

3.  A new scanning electron microscopy approach to the quantification of bone mineral distribution: backscattered electron image grey-levels correlated to calcium K alpha-line intensities.

Authors:  P Roschger; H Plenk; K Klaushofer; J Eschberger
Journal:  Scanning Microsc       Date:  1995-03

4.  Type V OI primary osteoblasts display increased mineralization despite decreased COL1A1 expression.

Authors:  Adi Reich; Alison S Bae; Aileen M Barnes; Wayne A Cabral; Aleksander Hinek; Jennifer Stimec; Suvimol C Hill; David Chitayat; Joan C Marini
Journal:  J Clin Endocrinol Metab       Date:  2014-11-11       Impact factor: 5.958

5.  Genotype-phenotype study in type V osteogenesis imperfecta.

Authors:  Meena Balasubramanian; Michael J Parker; Ann Dalton; Cecilia Giunta; Uschi Lindert; Luiz C Peres; Bart E Wagner; Paul Arundel; Amaka Offiah; Nicholas J Bishop
Journal:  Clin Dysmorphol       Date:  2013-07       Impact factor: 0.816

6.  Osteogenesis imperfecta without features of type V caused by a mutation in the IFITM5 gene.

Authors:  Monica Grover; Philippe M Campeau; Caressa Dee Lietman; James T Lu; Richard A Gibbs; Alan E Schlesinger; Brendan H Lee
Journal:  J Bone Miner Res       Date:  2013-11       Impact factor: 6.741

7.  Evidence for a Role for Nanoporosity and Pyridinoline Content in Human Mild Osteogenesis Imperfecta.

Authors:  Eleftherios P Paschalis; Sonja Gamsjaeger; Nadja Fratzl-Zelman; Paul Roschger; Admir Masic; Wolfgang Brozek; Norbert Hassler; Francis H Glorieux; Frank Rauch; Klaus Klaushofer; Peter Fratzl
Journal:  J Bone Miner Res       Date:  2016-02-11       Impact factor: 6.741

Review 8.  Bone mineralization density distribution in health and disease.

Authors:  P Roschger; E P Paschalis; P Fratzl; K Klaushofer
Journal:  Bone       Date:  2007-11-12       Impact factor: 4.398

9.  Clinical and Molecular Characterization of Osteogenesis Imperfecta Type V.

Authors:  Evelise Brizola; Eduardo P Mattos; Jessica Ferrari; Patricia O A Freire; Raquel Germer; Juan C Llerena; Têmis M Félix
Journal:  Mol Syndromol       Date:  2015-09-03

10.  A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus.

Authors:  Oliver Semler; Lutz Garbes; Katharina Keupp; Daniel Swan; Katharina Zimmermann; Jutta Becker; Sandra Iden; Brunhilde Wirth; Peer Eysel; Friederike Koerber; Eckhard Schoenau; Stefan K Bohlander; Bernd Wollnik; Christian Netzer
Journal:  Am J Hum Genet       Date:  2012-08-02       Impact factor: 11.043

View more
  24 in total

Review 1.  Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes.

Authors:  Roberta Besio; Chi-Wing Chow; Francesca Tonelli; Joan C Marini; Antonella Forlino
Journal:  FEBS J       Date:  2019-07-05       Impact factor: 5.542

2.  Clinical Phenotype and Bone Biopsy Characteristics in a Child with Proteus Syndrome.

Authors:  Ali Al Kaissi; Barbara M Misof; Franco Laccone; Stéphane Blouin; Paul Roschger; Susanne G Kircher; Mohammad Shboul; Gabriel T Mindler; Werner Girsch; Rudolf Ganger
Journal:  Calcif Tissue Int       Date:  2021-05-18       Impact factor: 4.333

Review 3.  Osteogenesis imperfecta and therapeutics.

Authors:  Roy Morello
Journal:  Matrix Biol       Date:  2018-03-11       Impact factor: 11.583

4.  Oro-dental and cranio-facial characteristics of osteogenesis imperfecta type V.

Authors:  Jean-Marc Retrouvey; Doaa Taqi; Faleh Tamimi; Didem Dagdeviren; Francis H Glorieux; Brendan Lee; Renna Hazboun; Deborah Krakow; V Reid Sutton
Journal:  Eur J Med Genet       Date:  2018-12-26       Impact factor: 2.708

5.  Melorheostotic Bone Lesions Caused by Somatic Mutations in MAP2K1 Have Deteriorated Microarchitecture and Periosteal Reaction.

Authors:  Nadja Fratzl-Zelman; Paul Roschger; Heeseog Kang; Smita Jha; Andreas Roschger; Stéphane Blouin; Zuoming Deng; Wayne A Cabral; Aleksandra Ivovic; James Katz; Richard M Siegel; Klaus Klaushofer; Peter Fratzl; Timothy Bhattacharyya; Joan C Marini
Journal:  J Bone Miner Res       Date:  2019-01-22       Impact factor: 6.741

Review 6.  Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Classical and Rare OI Types.

Authors:  Milena Jovanovic; Gali Guterman-Ram; Joan C Marini
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

7.  Osteocyte transcriptome mapping identifies a molecular landscape controlling skeletal homeostasis and susceptibility to skeletal disease.

Authors:  Scott E Youlten; John P Kemp; John G Logan; Elena J Ghirardello; Claudio M Sergio; Michael R G Dack; Siobhan E Guilfoyle; Victoria D Leitch; Natalie C Butterfield; Davide Komla-Ebri; Ryan C Chai; Alexander P Corr; James T Smith; Sindhu T Mohanty; John A Morris; Michelle M McDonald; Julian M W Quinn; Amelia R McGlade; Nenad Bartonicek; Matt Jansson; Konstantinos Hatzikotoulas; Melita D Irving; Ana Beleza-Meireles; Fernando Rivadeneira; Emma Duncan; J Brent Richards; David J Adams; Christopher J Lelliott; Robert Brink; Tri Giang Phan; John A Eisman; David M Evans; Eleftheria Zeggini; Paul A Baldock; J H Duncan Bassett; Graham R Williams; Peter I Croucher
Journal:  Nat Commun       Date:  2021-05-05       Impact factor: 14.919

8.  Increased Osteocyte Lacunae Density in the Hypermineralized Bone Matrix of Children with Osteogenesis Imperfecta Type I.

Authors:  Matthias Mähr; Stéphane Blouin; Martina Behanova; Barbara M Misof; Francis H Glorieux; Jochen Zwerina; Frank Rauch; Markus A Hartmann; Nadja Fratzl-Zelman
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

9.  A Clinical Perspective on Advanced Developments in Bone Biopsy Assessment in Rare Bone Disorders.

Authors:  Sanne Treurniet; Elisabeth M W Eekhoff; Felix N Schmidt; Dimitra Micha; Björn Busse; Nathalie Bravenboer
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-23       Impact factor: 5.555

10.  Craniocervical abnormalities in osteogenesis imperfecta type V.

Authors:  K Ludwig; C Seiltgens; A Ibba; N Saran; J A Ouellet; F Glorieux; F Rauch
Journal:  Osteoporos Int       Date:  2021-08-05       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.